# Precocious puberty

- Category: chronic
- Review status: reviewed (every claim checked against a document named on this page)
- Sources: Precocious Puberty - StatPearls (NCBI Bookshelf NBK544313) - https://www.ncbi.nlm.nih.gov/books/NBK544313/ · Precocious puberty - disease-level clinical article (precocious-puberty-full.txt) · Precocious puberty - disease-level clinical article (precocious-puberty-clinical.txt) · No dose - referral pathway, no medicine given in primary care
- Verified date: 2026-08

## Verified against

- Precocious Puberty - StatPearls (NCBI Bookshelf NBK544313) - https://www.ncbi.nlm.nih.gov/books/NBK544313/
- Precocious puberty - disease-level clinical article (precocious-puberty-full.txt)
- Precocious puberty - disease-level clinical article (precocious-puberty-clinical.txt)
- No dose - referral pathway, no medicine given in primary care

## Treatment metadata

- Referral & safety-netting (no drug therapy)

## Complete treatment card

```text
PRECOCIOUS PUBERTY
Sources: Precocious Puberty - StatPearls (NCBI Bookshelf NBK544313) -
         https://www.ncbi.nlm.nih.gov/books/NBK544313/ · Precocious puberty - disease-level clinical
         article (precocious-puberty-full.txt) · Precocious puberty - disease-level clinical article
         (precocious-puberty-clinical.txt) · No dose - referral pathway, no medicine given in
         primary care
Review status: REVIEWED against 4 sources listed above  (2026-08)

IS IT THIS? - reference only, to read alongside your own examination
  SYMPTOMS - what the patient reports (5)
    - True precocious puberty shows progressive multi-sign development, rapid growth, and advanced
      bone age, unlike benign variants which are isolated and non-progressive with age-appropriate
      bone age.
    - Fast-progressing puberty is considered abnormal even when it begins at a typical age.
    - Episodes of inappropriate laughing can point toward an underlying hypothalamic hamartoma.
    - The earliest signs are breast budding in girls and testicular volume of 4 mL or more in boys.
    - Lower abdominal pain on review of systems raises concern for an ovarian cause.  [abdominal
      pain · lower abdominal pain]
  SIGNS - what you find (4)
    - Clitoral or penile enlargement, acne, and body odor can suggest an androgen-secreting adrenal
      tumor.  [acne]
    - Pubic hair without testicular growth, or menstrual bleeding with little breast development,
      points to a peripheral cause.  [bleeding]
    - One-sided testicular enlargement raises suspicion for a testicular tumor.
    - Cafe-au-lait spots, neurofibromas, or bone deformities suggest neurofibromatosis type 1 or
      McCune-Albright syndrome.  [cafe-au-lait spots]
  TESTS (8)
    - Bone age more than 2 standard deviations ahead of chronological age warrants further workup.
    - An LH/FSH ratio below 0.43 suggests a prepubertal state.
    - A GnRH-stimulated LH/FSH ratio above 0.66 has been proposed to separate progressive from
      nonprogressive benign variants.
    - High sex-steroid levels with suppressed LH and FSH point to a peripheral, gonadotropin-
      independent cause.
    - hCG is checked in boys because some germ cell tumors secrete it, driving testosterone
      production via LH receptors.
    - Pelvic ultrasound showing uterine length over 3.5 to 4 cm and ovarian volume over 2 mL
      indicates puberty has begun.
    - Brain MRI is most useful in central precocious puberty when the child is under 6, has
      neurologic signs, or is a boy of any age.
    - A bone scan can detect subclinical fibrous dysplasia when McCune-Albright syndrome is
      suspected but bones look otherwise normal.
  IF NOT THIS - what else fits (4)
    - Premature thelarche has no other pubertal changes, with normal bone age, growth velocity, and
      hormone testing.
    - Premature adrenarche shows itself as early pubic or underarm hair, skin oiliness or odor, and
      acne appearing before age 8, without breast or testicular growth.
    - Isolated premature menarche is vaginal bleeding before age 8 occurring with no other pubertal
      signs.
    - Lipomastia is fatty breast tissue in girls with obesity that can be mistaken for true breast
      development.
  Source  Precocious puberty - disease-level clinical article (precocious-puberty-full.txt)
  Status  traced to the source above

1. REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)            [1st line]
   Adult    
   Source   Precocious Puberty - StatPearls (NCBI Bookshelf NBK544313) -
            https://www.ncbi.nlm.nih.gov/books/NBK544313/
   Why      The point of the referral is not the puberty; it is the brain tumour, the ovarian tumour
            and the congenital adrenal hyperplasia that can cause it. GnRH analogue treatment is a
            specialist decision and the cached article gives no primary-care amount for it, so no
            prescribing row is offered. What primary care owns is the age threshold, the growth
            chart, and telling the benign variants apart from the ones that must move quickly.
   Caution  THE AGE THRESHOLD - secondary sexual characteristics appearing before 8 years in a girl,
            or before 9 years in a boy. The major paediatric and endocrine societies back that cut-
            off, and it stays the point at which a diagnostic workup is started.
            SPEED COUNTS AS MUCH AS AGE - puberty that moves fast is abnormal even where it began at
            a normal age. True precocity shows several secondary sexual characteristics developing
            together, a fast rate of linear growth, and a bone age ahead of the child's years. The
            benign variants do the opposite: one isolated sign that does not progress, growth at a
            normal rate, and a bone age that matches the birthday.
            PLOT THE HEIGHT, EVERY TIME - a fast rate of linear growth is one of the key pointers to
            early puberty, so record height, weight, body mass index and the growth rate in
            centimetres per year accurately at every visit. A child sprinting up the centiles
            alongside early breast or testicular development is the one to move on.
            MOST OF IT IS BENIGN, AND THE BENIGN ONES HAVE NAMES - premature thelarche is breast
            tissue developing on one or both sides in a girl, either from birth to 24 months, or
            from 6 to 8 years - a bimodal peak - and it is the commonest of the benign variants.
            Nothing else pubertal comes with it, and the bone age, the growth velocity and the blood
            tests are all normal. Premature adrenarche is the early output of adrenal androgens:
            pubic or axillary hair, body odour, or acne before 8 years, with no breast development
            in a girl and no testicular enlargement in a boy.
            BUT DO NOT LABEL THEM AND WALK AWAY - premature thelarche needs frequent clinical
            follow-up so that growth and pubertal progression are watched. Premature adrenarche
            needs androgen exposure excluded first - creams and gels in the house, an adrenal
            tumour, late-onset congenital adrenal hyperplasia.
            BLEEDING IN A GIRL UNDER 8 IS A SAFEGUARDING QUESTION TOO - isolated vaginal bleeding
            has causes that must be excluded: sexual abuse, a foreign body in the vagina, a tumour
            of the genital tract, and infection of the vulva or vagina. Ask, examine appropriately,
            and use the child safeguarding pathway if anything does not fit.
            THE NEUROLOGICAL HISTORY THAT CHANGES EVERYTHING - ask about headaches, seizures, a head
            circumference that is growing, changes in vision or cognition, odd behaviour, or bouts
            of laughing at nothing, which can point to a hypothalamic hamartoma. Imaging follows:
            scanning the hypothalamic-pituitary axis by MRI is advised in central precocious
            puberty, and it yields most in a child under 6 years, in any child with neurological
            signs, and in a boy of any age. A boy with central precocity is a scan, full stop.
            ASK WHAT IS IN THE HOUSE - ask too about exposure, deliberate or accidental, to any
            cream, pill or supplement containing sex hormones. A parent's testosterone gel or an
            oestrogen cream on a shared bathroom shelf is a real and reversible cause.
            THE EXAMINATION FINDINGS THAT POINT AWAY FROM THE BRAIN - in a child of either sex with
            pubic hair and body odour, look for a peripheral cause where the testes are not
            enlarged, or where menarche has arrived with little breast development. Enlargement of
            one testis only can mean a testicular tumour. Look at the skin as well: cafe au lait
            macules, neurofibromas or bony deformity may mean type 1 neurofibromatosis, or McCune-
            Albright syndrome.
            THE FIRST TESTS TO SEND - the initial panel is a bone age, LH, FSH, oestrogen or
            testosterone, DHEA-S (dehydroepiandrosterone sulfate), 17-OH progesterone, and thyroid
            function. The wrist film is the cheap place to start, being non-invasive and easy, and a
            bone age running more than 2 standard deviations ahead of the child's actual age is what
            takes the workup further.
            WHY NOT TREATING HAS A COST - left untreated, the bone matures fast and the epiphyses
            close early, and the adult height that results is reduced; that is the main long-term
            worry in both sexes. Starting treatment early makes it likelier that final adult height
            is preserved. And there is the cost of missing the diagnosis: a serious underlying
            condition needing urgent medical or surgical treatment can go undetected.
            WHAT TO SAY WHILE THEY WAIT FOR THE APPOINTMENT - go through how puberty normally
            unfolds, and how a benign variant is told apart from an abnormal one. Cover the
            psychosocial side too - how the child gets on with peers, self-esteem, body image. On
            the treatment itself, where it is offered: complications of GnRH analogues are rare, and
            both short-term and long-term safety have been shown, with the hypothalamic-pituitary-
            gonadal axis returning to normal once therapy stops.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.
```

---

Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement.

[Privacy policy](/privacy)
